NO974371L - Epitelialadhesive lactobacilli - Google Patents
Epitelialadhesive lactobacilliInfo
- Publication number
- NO974371L NO974371L NO974371A NO974371A NO974371L NO 974371 L NO974371 L NO 974371L NO 974371 A NO974371 A NO 974371A NO 974371 A NO974371 A NO 974371A NO 974371 L NO974371 L NO 974371L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- mannose
- date sep
- sec
- strain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Denne oppfinnelse vedrører anvendelse av Lactobacillus plantarum som har et mannosespesifikt adhesin for fremstilling av en farmasøytisk blanding som inhiberer bindingen av patogene bakterier som uttrykker mannose-spesifikke adhesiner, til epitelcelleoverflaten. En stamme av Lactobacillus plantarum som kan anvendes i denne oppfinnelse, vil klebe til mannosebelagte agaroseperler, og tilhører fortrinnsvis en klynge av L. plantarum med mer enn 70% likhet med L. plantarum 299 med hensyn til REA. Oppfinnelsen refererer også til anvendelsen av nevnte stammer for fremstilling av en farmasøytisk blanding for anvendelse i profylaktisk eller kurativ behandling av bakteriell translokasjon, magekatarr og andre syk-dommer forårsaket av patogene bakterier som uttrykker mannosespesifikke adhesiner.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9501056A SE9501056D0 (sv) | 1995-03-23 | 1995-03-23 | Epithelial adherent lactobacilli |
PCT/SE1996/000372 WO1996029083A1 (en) | 1995-03-23 | 1996-03-25 | Epithelial adhesive lactobacilli |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974371D0 NO974371D0 (no) | 1997-09-22 |
NO974371L true NO974371L (no) | 1997-11-20 |
Family
ID=20397666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974371A NO974371L (no) | 1995-03-23 | 1997-09-22 | Epitelialadhesive lactobacilli |
Country Status (17)
Country | Link |
---|---|
US (1) | US6159465A (no) |
EP (1) | EP0817640B1 (no) |
JP (1) | JP4072646B2 (no) |
KR (1) | KR100446482B1 (no) |
CN (1) | CN1138551C (no) |
AT (1) | ATE240738T1 (no) |
AU (1) | AU702705B2 (no) |
BR (1) | BR9607538A (no) |
CA (1) | CA2216150C (no) |
DE (1) | DE69628288T2 (no) |
EE (1) | EE04097B1 (no) |
ES (1) | ES2200057T3 (no) |
HK (1) | HK1017989A1 (no) |
NO (1) | NO974371L (no) |
PL (1) | PL184037B1 (no) |
SE (1) | SE9501056D0 (no) |
WO (1) | WO1996029083A1 (no) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100376954B1 (ko) * | 1995-07-31 | 2003-07-18 | 프로비 에이비 | 장에서집락화하는유산간균 |
FI974643A (fi) * | 1997-12-30 | 1999-07-01 | Atria Oyj | Biologinen menetelmä salmonellan eliminoimiseksi prosesseista ja rakenteista |
AU764011B2 (en) * | 1998-10-01 | 2003-08-07 | Probi Ab | Reduction of oxidative stress factors |
WO2001010448A1 (en) * | 1999-08-09 | 2001-02-15 | University Of Maryland, Baltimore | Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
CN1281220C (zh) * | 1999-10-26 | 2006-10-25 | 雀巢制品公司 | 乳酸菌在制备治疗和/或预防贾第鞭毛虫病药物中的应用 |
GB2369777B (en) * | 2000-10-05 | 2004-10-27 | St Ivel Ltd | Food products with antimicrobial lactic acid bacteria |
SE0004124D0 (sv) * | 2000-11-10 | 2000-11-10 | Probi Ab | New use |
FR2831555A1 (fr) * | 2001-10-29 | 2003-05-02 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
FR2826020B1 (fr) * | 2001-06-14 | 2005-02-11 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes |
WO2002103034A1 (fr) * | 2001-06-14 | 2002-12-27 | Ceva Sante Animale | Procede de selection de souches de bacteries lactiques a gram positif non pathogenes |
SE527555C2 (sv) * | 2003-04-04 | 2006-04-11 | Probi Ab | Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar |
WO2005086870A2 (en) * | 2004-03-10 | 2005-09-22 | The Board Of Trustees Of The University Of Illinois | Novel lactobacillus strains and method of use |
ATE466023T1 (de) * | 2004-03-23 | 2010-05-15 | Friesland Brands Bv | Mannose-spezifische adhesinen und deren vervendung |
SE528382C2 (sv) * | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
JP2006180836A (ja) * | 2004-12-28 | 2006-07-13 | Marudai Food Co Ltd | 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物 |
JP2006257077A (ja) * | 2005-02-18 | 2006-09-28 | Marudai Food Co Ltd | 免疫調節剤および免疫調節食品 |
CN1888051B (zh) * | 2005-06-28 | 2010-05-05 | 北京天佑达生物工程科技有限公司 | 一株植物乳杆菌及其应用 |
SE529199C2 (sv) * | 2005-07-05 | 2007-05-29 | Probi Ab | Förstärkt absorption |
ES2561629T3 (es) | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Tratamiento del SII usando como efectores de tratamiento tanto bacterias probióticas como cereales fermentados |
CA2630823C (en) | 2005-12-13 | 2015-02-10 | Exthera Ab | Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
PL210465B1 (pl) | 2007-06-04 | 2012-01-31 | Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna | Zastosowanie kompozycji szczepów z rodzaju Lactobacillus |
FR2928935B1 (fr) | 2008-03-19 | 2011-05-20 | Gervais Danone Sa | Souche de lactobacillus rhamnosus. |
CN102470152A (zh) | 2009-07-30 | 2012-05-23 | 丹尼斯科公司 | 用于治疗内毒素血症的乳酸菌和双歧杆菌 |
CA2782311C (en) | 2009-12-01 | 2017-06-27 | Robert S. Ward | Method for removing cytokines from blood with surface immobilized polysaccharides |
BR112012018813B1 (pt) | 2010-01-28 | 2020-12-08 | Ab-Biotics S.A. | composição compreendendo cepas bacterianas com atividade anti-inflamatória, imunomoduladora, antiibs ou antidistensão abdominal, uso das mesmas, bem como produtos farmacêutico, veterinário e comestível compreendendo a referida composição |
WO2012112724A1 (en) | 2011-02-15 | 2012-08-23 | Exthera Medical, Llc | Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines |
BG66608B1 (bg) * | 2011-05-04 | 2017-10-16 | "Ел Би Булгарикум" ЕАД | Полибактериален пробиотичен препарат |
CN102618456B (zh) * | 2012-02-28 | 2013-08-21 | 江南大学 | 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途 |
WO2013188073A1 (en) | 2012-06-13 | 2013-12-19 | Exthera Medical, Llc | Use of heparin and carbohydrates to treat cancer |
JP2012184261A (ja) * | 2012-06-21 | 2012-09-27 | Snow Brand Milk Products Co Ltd | 免疫増強剤 |
CN102827796B (zh) * | 2012-09-03 | 2013-10-30 | 江南大学 | 一种具有排镉功能的植物乳杆菌及其用途 |
WO2014047625A1 (en) | 2012-09-24 | 2014-03-27 | Montana State University | Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use |
JP6648009B2 (ja) * | 2013-06-24 | 2020-02-14 | エクステラ・メディカル・コーポレーション | マンノース被覆基材を含有する血液濾過システム |
AU2014346668C1 (en) | 2013-11-08 | 2018-04-26 | Exthera Medical Corporation | Methods for diagnosing infectious diseases using adsorption media |
DE15782250T1 (de) | 2014-04-24 | 2017-08-10 | Exthera Medical Corporation | Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate |
CN106714669B (zh) | 2014-09-22 | 2021-05-14 | 艾克塞拉医疗公司 | 可穿戴的血液灌流装置 |
WO2017058175A1 (en) | 2015-09-29 | 2017-04-06 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
US11911551B2 (en) | 2016-03-02 | 2024-02-27 | Exthera Medical Corporation | Method for treating drug intoxication |
US10786615B2 (en) | 2016-03-02 | 2020-09-29 | Exthera Medical Corporation | Method for treating drug intoxication |
KR102024883B1 (ko) | 2017-11-24 | 2019-09-24 | 주식회사 고바이오랩 | 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도 |
SG11202010944RA (en) | 2018-05-09 | 2020-12-30 | Ko Biolabs Inc | Lactobacillus paracasei strain and use thereof |
CA3101175A1 (en) | 2018-05-23 | 2019-11-28 | Ko Biolabs, Inc. | Lactobacillus gasseri kbl697 strain and use thereof |
CN114007434A (zh) | 2019-06-05 | 2022-02-01 | 森永乳业株式会社 | 营养组合物 |
CN111575223B (zh) * | 2020-05-20 | 2022-04-15 | 江南大学 | 一种降低鼠李糖乳杆菌表面物质分泌量的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0203586A3 (en) * | 1985-05-29 | 1988-03-09 | Pioneer Hi-Bred International | A composition for treating gastrointestinal disease in animals |
SE469875C (sv) * | 1991-07-25 | 1997-02-05 | Probi Ab | Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen |
GB9124249D0 (en) * | 1991-11-14 | 1992-01-08 | Goldstein Fredric | Ribbon curling and shredding device |
GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
-
1995
- 1995-03-23 SE SE9501056A patent/SE9501056D0/xx unknown
-
1996
- 1996-03-25 WO PCT/SE1996/000372 patent/WO1996029083A1/en active IP Right Grant
- 1996-03-25 JP JP52834796A patent/JP4072646B2/ja not_active Expired - Lifetime
- 1996-03-25 EP EP96908428A patent/EP0817640B1/en not_active Expired - Lifetime
- 1996-03-25 DE DE69628288T patent/DE69628288T2/de not_active Expired - Lifetime
- 1996-03-25 PL PL96322550A patent/PL184037B1/pl unknown
- 1996-03-25 AU AU51665/96A patent/AU702705B2/en not_active Expired
- 1996-03-25 EE EE9700329A patent/EE04097B1/xx unknown
- 1996-03-25 ES ES96908428T patent/ES2200057T3/es not_active Expired - Lifetime
- 1996-03-25 CA CA002216150A patent/CA2216150C/en not_active Expired - Lifetime
- 1996-03-25 US US08/913,618 patent/US6159465A/en not_active Expired - Lifetime
- 1996-03-25 BR BR9607538A patent/BR9607538A/pt not_active Application Discontinuation
- 1996-03-25 CN CNB961940867A patent/CN1138551C/zh not_active Expired - Lifetime
- 1996-03-25 AT AT96908428T patent/ATE240738T1/de active
- 1996-03-25 KR KR1019970706504A patent/KR100446482B1/ko not_active IP Right Cessation
-
1997
- 1997-09-22 NO NO974371A patent/NO974371L/no not_active Application Discontinuation
-
1998
- 1998-10-19 HK HK98111312A patent/HK1017989A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2216150A1 (en) | 1996-09-26 |
EP0817640B1 (en) | 2003-05-21 |
PL184037B1 (pl) | 2002-08-30 |
ATE240738T1 (de) | 2003-06-15 |
EE04097B1 (et) | 2003-08-15 |
EP0817640A1 (en) | 1998-01-14 |
EE9700329A (et) | 1998-06-15 |
NO974371D0 (no) | 1997-09-22 |
KR19980703102A (ko) | 1998-10-15 |
ES2200057T3 (es) | 2004-03-01 |
HK1017989A1 (en) | 1999-12-10 |
KR100446482B1 (ko) | 2006-01-27 |
JPH11502703A (ja) | 1999-03-09 |
DE69628288T2 (de) | 2004-04-08 |
BR9607538A (pt) | 1998-01-06 |
WO1996029083A1 (en) | 1996-09-26 |
CN1185111A (zh) | 1998-06-17 |
CN1138551C (zh) | 2004-02-18 |
CA2216150C (en) | 2008-01-22 |
DE69628288D1 (de) | 2003-06-26 |
US6159465A (en) | 2000-12-12 |
AU702705B2 (en) | 1999-03-04 |
PL322550A1 (en) | 1998-02-02 |
SE9501056D0 (sv) | 1995-03-23 |
AU5166596A (en) | 1996-10-08 |
JP4072646B2 (ja) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974371D0 (no) | Epitelialadhesive lactobacilli | |
Coconnier et al. | Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion | |
Prince et al. | Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion | |
AU6040001A (en) | Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders | |
Delley et al. | In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli | |
HU9603251D0 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
AU3002699A (en) | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypesthereof, using microbial uc panca antigens | |
BR0011038A (pt) | Composição farmacêutica ou dietética para uso na prevenção ou tratamento da hiperoxalúria | |
DE69839699D1 (de) | Vaginales lactobacillus-medikament | |
BR9916062A (pt) | Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital | |
HUP0200206A2 (hu) | Tejsavbaktérium-törzsek hasmenés megelőzésére | |
WO2002083879A3 (en) | Immunotherapy based on dendritic cells | |
Neilands et al. | Parvimonas micra stimulates expression of gingipains from Porphyromonas gingivalis in multi-species communities | |
BR0314511A (pt) | Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater | |
NZ335086A (en) | Bacillus thuringiensis pesticidal toxins and nucleotide sequences which encode these toxins | |
EE03597B1 (et) | Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini | |
Viboud et al. | Binding of enterotoxigenicEscherichia coliexpressing different colonization factors to tissue-cultured Caco-2 cells and to isolated human enterocytes | |
Henriksson et al. | Adhesion of Lactobacillus fermentum 104-S to porcine stomach mucus | |
AU4626096A (en) | Immunoenzymatic conjugate, preparation method therefor and uses thereof | |
WO2000067583A3 (en) | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels | |
Rosenstein | The use of lipid-linked oligosaccharides (neoglycolipids) in the identification of carbohydrate receptors for microbial pathogens | |
MD20010055A (ro) | Preparat microbian sanogenic pentru profilaxia şi tratamentul disbacteriozei intestinale | |
MD20010076A (ro) | Preparat microbian sanogenic pentru asanarea tubului digestiv şi tratamentul disbacteriozei | |
MD781B1 (en) | Selective medium for separation of Streptococcus bacteries | |
GEP20033132B (en) | Bacteriological Preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |